Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Operating-Income" stands at 165.09 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2023.
Shionogi & Co. Ltd.'s first quarter result of 35.10 Billion JPY for the item "Operating Income" represents an increase of 24.89 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of 35.10 Billion JPY for the item "Operating Income" represents an increase of 24.86 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 165.09 Billion JPY for the item "Operating Income" represents an increase of 4.42 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.94 percent compared to the value the year prior.
The 1 year change in percent is 13.94.
The 3 year change in percent is 58.83.
The 5 year change in percent is 25.05.
The 10 year change in percent is 200.98.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Income | 280,205,508,085.11 |